🔗 Permalink

Assignee profile:

Intima Bioscience, Inc.

City:

New York, New York

Country:

United States

Published Applications:

Last publication date:

2023-07-27

Patent Grants:

Last grant date:

2026-01-27

Top Inventors for applications by Intima Bioscience, Inc.

These are the the leading inventors for applications assigned to Intima Bioscience, Inc.:

Modassir Choudhry 12 New York, NY United States
Beau Webber 11 Coon Rapids, MN United States
Steven A. Rosenberg 11 Potomac, MD United States
Branden Moriarity 11 Shoreview, MN United States

Douglas C. PALMER 10 North Bethesda, MD United States
Nicholas P. Restifo 10 Chevy Chase, MD United States
R. Scott McIvor 3 St. Louis Park, MN United States
Xueqiu Lin 3 San Bruno, CA United States

David Largaespada 3 Mounds View, MN United States
LEI S. QI 3 Stanford, CA United States
Modassir S. Choudhry 2 New York, NY United States
Xiaoshu Xu 2 Millbrae, CA United States

Sejla Salic 1 Vienna, Austria
Thomas Henley 1 Soham, United Kingdom
Benjamin Klapholz 1 Cambridge, United Kingdom
Tilmann BUERCKSTUEMMER 1 Vienna, Austria

Trevor N. Collingwood 1 Novato, CA United States

Recent patent applications by Intima Bioscience, Inc.

Intima Bioscience, Inc. based in New York, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-07-27

US20230235324A1

Chemistry; metallurgy

NUCLEASE SYSTEMS FOR GENETIC ENGINEERING

#2 | 2022-03-24 ✅ Patent 12,534,499 granted on 2026-01-27

US20220089659A1

Chemistry; metallurgy

MESOPHILIC ARGONAUTE SYSTEMS AND USES THEREOF

#3 | 2021-08-26 ✅ Patent 11,583,556 granted on 2023-02-21

US20210260117A1

Human necessities

Modified cells and methods of therapy

#4 | 2021-01-28 ✅ Patent 11,447,774 granted on 2022-09-20

US20210024924A1

Chemistry; metallurgy

Nuclease systems for genetic engineering

#5 | 2020-11-12 ✅ Patent 11,925,664 granted on 2024-03-12

US20200353001A1

Human necessities

Intracellular genomic transplant and methods of therapy

#6 | 2020-10-01 ✅ Patent 11,266,692 granted on 2022-03-08

US20200306310A1

Human necessities

Intracellular genomic transplant and methods of therapy

#7 | 2020-09-17 ✅ Patent 11,154,574 granted on 2021-10-26

US20200289570A1

Human necessities

Tumor infiltrating lymphocytes and methods of therapy

#8 | 2019-02-28 ✅ Patent 11,642,375 granted on 2023-05-09

US20190060364A1

Human necessities

Intracellular genomic transplant and methods of therapy

#9 | 2019-02-28 ✅ Patent 11,642,374 granted on 2023-05-09

US20190060363A1

Human necessities

Intracellular genomic transplant and methods of therapy

#10 | 2019-02-21 ✅ Patent 11,903,966 granted on 2024-02-20

US20190054122A1

Human necessities

Intracellular genomic transplant and methods of therapy

#11 | 2019-01-10 ✅ Patent 10,912,797 granted on 2021-02-09

US20190008899A1

Human necessities

Tumor infiltrating lymphocytes and methods of therapy

#12 | 2017-05-11 ✅ Patent 10,166,255 granted on 2019-01-01

US20170130200A1

Chemistry; metallurgy

Intracellular genomic transplant and methods of therapy

#13 | 2017-03-09 ✅ Patent 11,147,837 granted on 2021-10-19

US20170067021A1

Chemistry; metallurgy

Modified cells and methods of therapy

#14 | 2017-03-09 ✅ Patent 10,406,177 granted on 2019-09-10

US20170065636A1

Human necessities

Modified cells and methods of therapy

Also check out Intima Bioscience, Inc.'s (New York, United States) applicant profile with 15 patent applications submitted.

AssigneeID:

306836 ⎘